Project

Single domain antibodies that neutralize SARS-CoV-2

Code
01C02620
Looptijd
15-04-2020 → 14-01-2021
Financiering
Regional and community funding: Special Research Fund
Onderzoeksdisciplines
  • Natural sciences
    • Infectious diseases
    • Virology
  • Engineering and technology
    • Medical molecular engineering of nucleic acids and proteins
Trefwoorden
Coronavirus antilichaam virusneutralizatie
 
Projectomschrijving

The aim of this project is to isolate single domain antibodies that are directed against the receptor-binding domain that is part of the spike protein of SARS-CoV-2. Those single-domain antibodies, separately and combined, will be evaluated for their capacity to neutralize SARS-CoV-2.